[{"id":"34339220-1770-4108-8649-484d7d43cefa","acronym":"212-Pb-VMT","url":"https://clinicaltrials.gov/study/NCT05636618","created_at":"2022-12-05T15:56:36.062Z","updated_at":"2025-02-25T17:38:15.153Z","phase":"Phase 1/2","brief_title":"Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors","source_id_and_acronym":"NCT05636618 - 212-Pb-VMT","lead_sponsor":"Perspective Therapeutics","biomarkers":" SSTR • CD4 • SSTR2","pipe":" | ","alterations":" SSTR2 expression • SSTR2 positive","tags":["SSTR • CD4 • SSTR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR2 expression • SSTR2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VMT-𝛼-NET"],"overall_status":"Recruiting","enrollment":" Enrollment 280","initiation":"Initiation: 09/27/2023","start_date":" 09/27/2023","primary_txt":" Primary completion: 11/26/2029","primary_completion_date":" 11/26/2029","study_txt":" Completion: 12/26/2029","study_completion_date":" 12/26/2029","last_update_posted":"2025-01-29"}]